Tolka AI Therapeutics
Tolka AI Therapeutics is a biotechnology company focused on developing personalized phage therapy solutions for hard-to-treat, antibiotic-resistant infections. By integrating agentic artificial intelligence, robotics, and advanced manufacturing, the company enables scalable, tailored therapies targeting pathogens such as Mycobacterium abscessus. Tolka leverages a proprietary phage library, automated platforms, and clinical research programs to accelerate access to safe and effective alternatives where conventional treatments are inadequate.
Industries
N/A
Tolka AI Therapeutics
Products
A platform integrating large language model agents, robotics, and predictive models for authoring FDA-compliant batch records, executing laboratory automation, and continuous improvement of tailored phage therapies.
A comprehensive collection of bacteriophages characterized for activity against Mycobacterium abscessus isolates, serving as a resource for both clinical and research applications.
A platform integrating large language model agents, robotics, and predictive models for authoring FDA-compliant batch records, executing laboratory automation, and continuous improvement of tailored phage therapies.
A comprehensive collection of bacteriophages characterized for activity against Mycobacterium abscessus isolates, serving as a resource for both clinical and research applications.
Services
Provision of investigational, patient-specific phage therapies for non-tuberculous mycobacterial lung disease under the FDA expanded access (compassionate use) program.
Collection and secure storage of patient-derived respiratory isolates to support the development of personalized phage therapies and related clinical research.
Provision of investigational, patient-specific phage therapies for non-tuberculous mycobacterial lung disease under the FDA expanded access (compassionate use) program.
Collection and secure storage of patient-derived respiratory isolates to support the development of personalized phage therapies and related clinical research.
Expertise Areas
- Bacteriophage-based therapeutics
- AI-driven drug discovery
- Infectious disease clinical research
- Personalized medicine
Key Technologies
- Phage therapy
- Agentic AI systems
- Large language models
- Predictive modeling
Key People
News & Updates
Discusses advances in generating superphages and optimizing phage cocktails to address antibiotic resistance and microbiome dysbiosis.
Covers Tolka’s approach to tackling antibiotic resistance through the integration of AI and phage therapy.
Podcast episode featuring insights into the development and vision behind AI-enabled precision medicine for infectious diseases.
Discusses advances in generating superphages and optimizing phage cocktails to address antibiotic resistance and microbiome dysbiosis.
Covers Tolka’s approach to tackling antibiotic resistance through the integration of AI and phage therapy.
Podcast episode featuring insights into the development and vision behind AI-enabled precision medicine for infectious diseases.